Main Street Research’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.67M | Buy |
2,908
+1,489
| +105% | +$1.51M | 0.16% | 48 |
|
|
2025
Q4 | $1.53M | Sell |
1,419
-1,262
| -47% | -$1.21M | 0.09% | 49 |
|
|
2025
Q3 | $2.05M | Buy |
2,681
+2
| +0.1% | +$1.49K | 0.11% | 52 |
|
|
2025
Q2 | $2.09M | Sell |
2,679
-660
| -20% | -$513K | 0.13% | 45 |
|
|
2025
Q1 | $2.76M | Sell |
3,339
-24
| -0.7% | -$20K | 0.18% | 46 |
|
|
2024
Q4 | $2.6M | Buy |
3,363
+61
| +2% | +$50.5K | 0.16% | 46 |
|
|
2024
Q3 | $2.93M | Buy |
3,302
+24
| +0.7% | +$21.6K | 0.18% | 46 |
|
|
2024
Q2 | $2.97M | Sell |
3,278
-3
| -0.1% | -$2.4K | 0.2% | 42 |
|
|
2024
Q1 | $2.55M | Buy |
3,281
+149
| +5% | +$106K | 0.17% | 44 |
|
|
2023
Q4 | $1.83M | Buy |
3,132
+103
| +3% | +$60.1K | 0.15% | 47 |
|
|
2023
Q3 | $1.63M | Buy |
3,029
+4
| +0.1% | +$2.06K | 0.17% | 50 |
|
|
2023
Q2 | $1.42M | Sell |
3,025
-67
| -2% | -$28.1K | 0.23% | 41 |
|
|
2023
Q1 | $1.06M | Buy |
3,092
+65
| +2% | +$21.9K | 0.21% | 41 |
|
|
2022
Q4 | $1.11M | Sell |
3,027
-4
| -0.1% | -$1.42K | 0.27% | 35 |
|
|
2022
Q3 | $980K | Buy |
3,031
+76
| +3% | +$24.1K | 0.22% | 38 |
|
|
2022
Q2 | $958K | Buy |
2,955
+52
| +2% | +$15.6K | 0.25% | 33 |
|
|
2022
Q1 | $831K | Buy |
2,903
+128
| +5% | +$32.9K | 0.08% | 52 |
|
|
2021
Q4 | $767K | Buy |
2,775
+7
| +0.3% | +$1.77K | 0.06% | 67 |
|
|
2021
Q3 | $640K | Sell |
2,768
-20
| -0.7% | -$4.94K | 0.06% | 73 |
|
|
2021
Q2 | $640K | Buy |
2,788
+7
| +0.3% | +$1.41K | 0.05% | 79 |
|
|
2021
Q1 | $520K | Buy |
2,781
+784
| +39% | +$153K | 0.05% | 82 |
|
|
2020
Q4 | $337K | Buy |
+1,997
| New | +$298K | 0.04% | 90 |
|
|
2016
Q4 | – | Sell |
-3,690
| Closed | -$296K | – | 113 |
|
|
2016
Q3 | $296K | Sell |
3,690
-70
| -2% | -$5.6K | 0.06% | 91 |
|
|
2016
Q2 | $296K | Buy |
3,760
+114
| +3% | +$8.58K | 0.06% | 90 |
|
|
2016
Q1 | $263K | Sell |
3,646
-125
| -3% | -$9.46K | 0.07% | 82 |
|
|
2015
Q4 | $318K | Hold |
3,771
| – | – | 0.07% | 97 |
|
|
2015
Q3 | $308K | Buy |
3,771
+56
| +2% | +$4.73K | 0.07% | 97 |
|
|
2015
Q2 | $310K | Sell |
3,715
-150
| -4% | -$11.4K | 0.06% | 114 |
|
|
2015
Q1 | $281K | Hold |
3,865
| – | – | 0.06% | 118 |
|
|
2014
Q4 | $267K | Buy |
3,865
+140
| +4% | +$9.45K | 0.06% | 118 |
|
|
2014
Q3 | $242K | Hold |
3,725
| – | – | 0.05% | 126 |
|
|
2014
Q2 | $232K | Hold |
3,725
| – | – | 0.05% | 124 |
|
|
2014
Q1 | $219K | Buy |
+3,725
| New | +$208K | 0.05% | 132 |
|
Other funds holding LLY
VCM
VPM
Main Street Research's LLY Position: Q1 2026 in Review
Main Street Research increased its Eli Lilly (LLY) stake by 105% in Q1 2026, buying an estimated $1.51M and bringing the position to 2,908 shares worth $2.67M. The position accounts for 0.16% of the portfolio, ranked #48.
Main Street Research first reported a position in LLY in Q1 2014 and has held it in 33 quarters since. The position peaked at $2.97M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Main Street Research held 2,908 shares of Eli Lilly worth $2.67M as of Q1 2026.
- Main Street Research bought 1,489 Eli Lilly shares in Q1 2026, an estimated $1.51M.
- Eli Lilly made up 0.16% of Main Street Research's portfolio in Q1 2026, its #48 holding.
- Main Street Research first reported a position in Eli Lilly in Q1 2014 and has held it in 33 quarters since.
- Main Street Research's Eli Lilly position peaked at $2.97M in Q2 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Main Street Research's 13F filing for Q1 2026, filed 30 Apr 2026.